JOHN ALDINGER: Open Payments
NPI 1578072328 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 36 payments from 7 companies in 2025. Trend: 2023 $1,802 · 2024 $1,989 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 26 | $447 |
| ViiV Healthcare Company | 5 | $101 |
| Novo Nordisk Inc | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| EMD Serono, Inc. | 1 | $18 |
| Napo Pharmaceuticals Inc | 1 | $17 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: APRETUDE, Biktarvy, DOVATO, Wegovy, Yeztugo, PIFELTRO, Mytesi, XYOSTED.
Industry payments across AZ — which companies pay providers there.
